Diabetology
News
Drugs
Xagena Medicine
Xagena.net
Diabetes, early infection intervention can avoid amputation
Type 1 and 2 diabetes: Exubera appears safe and effective
Exenatide improves blood glucose as effectively as Insulin Glargine
Januvia in the treatment for diabetes mellitus type 2
Type 2 diabetes: Galvus improves function of pancreatic islets and glycemic control
Ruboxistaurin shows favorable effects in type 2 diabetes and diabetic nephropathy
A new gene implicated in the cause of diabetes mellitus type 2 discovered
Diabetic retinopathy may occur in pre-diabetes
High risk of cardiovascular disease for boys with diabetes mellitus type 1
Diabetes mellitus type 2: Exenatide shows sustained improvements in glucose control and progressive weight reduction
Acomplia lowers blood glucose, reduces weight, waist size, and modifies lipids in diabetes mellitus type 2
Effects of Galida on glucose and lipid abnormalities in diabetes mellitus type 2
Pargluva reduces blood glucose versus Actos in type 2 diabetes
Rosiglitazone may reduce blood pressure in diabetes mellitus type 2
Duloxetine produces improvements in painful diabetic neuropathy
Lowering resistance to insulin may delay or prevent onset of diabetes mellitus type 2
Link between hyperglycemia, overexpression of PKC-beta 2 and kidney disease is confirmed
Weight control protects against low birth weight related glucose intolerance
Men with diabetes mellitus more likely to have low testosterone
Islet transplantation, a woman is insulin-free
IkB kinase beta, a pro-inflammatory enzyme linked to type 2 diabetes
Patients with diabetes more sensitive to cardiovascular effects from air pollution
Diabetes mellitus type 2: how much exercise is enough ?
Diabetes mellitus: hyperglycemia slows mental functions
Pargluva decreases HA1c levels in patients with type 2 diabetes
Actos reduces carotid artery intima-media thickness
Diabetic retinopathy: Minocycline may slow or prevent retinal damage
Low-fat dairy products may lower the risk of type 2 diabetes
FDA has approved Byetta in patients with type 2 diabetes
Byetta reduces HbA1c in patients poorly controlled on Metformin
Next Pages
1
2
[
3
]
4
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions
